Delegat Group Limited (NZE:DGL)

Inozyme Pharma Revenue

Delegat Group had revenue of 178.64M NZD in the half year ending December 31, 2024, a decrease of -14.59%. This brings the company's revenue in the last twelve months to 353.91M, down -5.72% year-over-year. In the fiscal year ending June 30, 2024, Delegat Group had annual revenue of 378.35M, down -0.81%.

• Revenue (ttm): 353.91M
• Revenue Growth: -5.72%
• P/S Ratio: 1.13
• Revenue / Employee: 884.78K
• Employees: 400
• Market Cap: 398.45M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	378.35M	-3.10M	-0.81%
Jun 30, 2023	381.44M	55.88M	17.16%
Jun 30, 2022	325.57M	20.19M	6.61%
Jun 30, 2021	305.38M	1.20M	0.39%
Jun 30, 2020	304.18M	26.21M	9.43%